AzTrials
AzTrials

Exercise CapacityNCT06805422

Health-Related Physical Fitness Level From Smartwatches

An observational study of Exercise Capacity and Flexibility, run by Kansas State University at 1 site in United States.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Health-related physical fitness (HRPF) has demonstrated high clinical relevance, and its level is associated with the ability to perform activities of daily living with vigor and a lower risk of chronic disease. Read more about this study

Who is it for?
Ages 20 to 60 yearsHealthy volunteers can take part
How many people
80 participants
Where
1 siteUnited States
Study dates
1 Jan 2025to 25 Dec 2025
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: he study population consists of healthy adult individuals categorized into four distinct groups based on their physical activity habits and fitness characteristics. These groups include: Aerobically Trained Individuals Participants actively engaged in aerobic exercise training (e.g., running, cycling, swimming) for at least two years. Likely to have higher cardiovascular fitness and endurance levels compared to other groups. Strength-Trained Individuals Participants actively engaged in regular weight training or resistance exercises. Expected to exhibit higher levels of muscle strength and hypertrophy. Non-Training Individuals Participants who are not engaged in regular aerobic or weight training exercises. Represent a baseline or control group with typical sedentary or minimally active lifestyles. Highly Flexible Individuals Participants identified by achieving high scores on flexibility assessments, regardless of their training status. Expected to have greater joint range of mot

Who may be able to join

  • Group 1 (Aerobically Trained)
  • 20-60 years old
  • actively training or competing over the past 2 years
  • 3 or more days of vigorous activity accumulating approximately least 1500 MET min/week or 7 days of any combination of walking, moderate, or vigorous intense activities achieving a minimum of 3000 MET min/week
  • Group 2 (Strength trained)
  • 20-60 years old
Show all 15Show fewer
  • actively training or competing over the past 2 years
  • 3 or more days of muscle-strengthening exercise at an intensity of approximately 5 out of 10
  • Group 3 (Not actively training)
  • 20-60 years old
  • actively training or competing over the past 2 years
  • 3 or more days of muscle-strengthening exercise at an intensity of approximately 5 out of 10
  • Group 5 (High flexibility)
  • 20-60 years old
  • Sit-and-reach performance is categorized as "very good" or excellent based on the American College of Sports Medicine's sit-and-reach evaluation criteria (Table 4.16 of ACSM's Guidelines for Exercise Testing and Prescription 9th edition).

Who cannot join

  • History of cardiovascular disease (Cardiac, peripheral vascular, or cerebrovascular disease)
  • History of stable or unstable angina
  • History of cardiac dysrhythmias causing symptoms or hemodynamic consequences
  • History of hypertrophic cardiomyopathy
  • History of cardiac valvular disease (e.g., aortic stenosis)
  • History of pulmonary disease (Chronic obstructive pulmonary disease, asthma, interstitial lung disease, or cystic fibrosis)
Show all 22Show fewer
  • History of pulmonary embolus
  • History of suspected or known aneurysm
  • History of metabolic disease (Diabetes mellitus (type I or II), thyroid disorders, renal or liver disease
  • History of renal disease
  • History of neuromotor, musculoskeletal, or rheumatoid disorders that are exacerbated by exercise
  • Current acute systemic infection, accompanied by fever and body aches.
  • Pain or discomfort in the chest, neck, jaw, arms, or other areas that may be due to myocardial ischemia (lack of adequate circulation)
  • Shortness of breath at rest, during daily activities, or with mild exertion
  • Dizziness or syncope (fainting)
  • Orthopnea (breathing discomfort when not in an upright position) or paroxysmal nocturnal dyspnea (interrupted breathing at night)
  • Ankle edema (swelling)
  • Palpitations (abnormal rapid beating of the heart) or tachycardia (rapid heartbeat)
  • Intermittent claudication (cramping pain and weakness in legs, especially calves, during walking due to inadequate blood supply to muscles)
  • Known heart murmur (atypical heart sound indicating a structural or functional abnormality)
  • Unusual or unexplained fatigue
  • Severe arterial hypertension (i.e., systolic blood pressure of >200 mm Hg and/or a diastolic blood pressure of >110 mm Hg) at rest.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Kansas State Univeristy

    Manhattan, Kansas, 66506

Other trials in United States

About this study

Health-related physical fitness (HRPF) has demonstrated high clinical relevance, and its level is associated with the ability to perform activities of daily living with vigor and a lower risk of chronic disease. Consequently, exercise prescription guidelines recommend improving HRPF as a focus for prevention and rehabilitation programs. Measuring and tracking HRPF often requires specialized equipment and personnel, which are expensive and less applicable to the general population. Wearables may mitigate this issue by providing useful estimates of the HRPF.

Read the detailed description

Health-related physical fitness (HRPF) has high clinical relevance [1]. It is associated with the ability to perform activities of daily living with vigor and a lower risk of chronic disease [2]. Consequently, exercise prescription guidelines recommend improving HRPF as a focus for prevention and rehabilitation programs [3]. The American College of Sports Medicine (ACSM) [3] grouped the HRFP into five domains: cardiorespiratory endurance, body composition, muscular strength, muscular endurance, and flexibility. However, measuring and tracking the fitness levels for all HRPF domains requires specialized laboratory equipment and personnel, which are expensive and less applicable to the general population. Wearable technology mitigates this issue and has proven to be a reliable alternative capable of providing useful estimates of the HRPF [4] [5] [6, 7]. Previous work has predicted ACSM HRPF domains from anthropometric and laboratory bioelectrical impedance analysis data (BIA) [8] [9]. Nevertheless, their data are based on the National Fitness Award (NFA), a nationwide test used to assess the physical fitness of the general South Korean population that is collected using specialized laboratory equipment under the supervision of health professionals.

Current advances in wearables may allow us to estimate the fitness level for all HRPF domains using only smartwatch data, enabling economic, non-intrusive predictions and being available during the user's daily routine. The complete characterization of health-related fitness as a multidimensional depiction of the user's fitness status can be used to track health status continuously and to design specialized training prescriptions. The main goal of this study is to estimate the fitness level for all HRFP domains from data obtained from smartwatches during unsupervised activities of daily living. We hypothesized that data from smartwatches could be used to estimate the fitness levels from all HRPF domains.

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT06805422
Study groupRoleWhat they receive
Aerobically trainedactively engaged in aerobic exercise training for at least 2 years
Strength trainedactively engaged in weight training
Not actively trainingnot engaged in regular aerobic or weight training exercise
Highly flexibledetermined by their flexibility scores

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Maximum Oxygen Consumption (VO2max)

    Maximum oxygen consumption (VO2max) will be measured using a standard Ramp protocol on a standardized treadmill.

    Measured: Performed 14-day after wearing the smartwatch

Secondary outcomes (3)
  1. % fat free mass

    Bio-electrical impedance will be used to assess % fat free mass

    Measured: Performed at baseline and 14-days after wearing the smartwatch

  2. Sit-and-reach distance

    Following a brief warm-up (including stretching exercises, cycling, or treadmill (less than 5 minutes)), participants will be instructed to sit on the floor with their legs extended and feet flat, without shoes, against the front of the test box. Upon command, the participant will slowly and steadily lean forward at the hips, keeping the knees straight and sliding their hand up the ruler as far as possible, ensuring that both hands reach an equal distance during the test and that the subject's knees remain grounded. The distance reached in centimeters will be recorded.

    Measured: Performed at baseline and 14-days after wearing the smartwatch

  3. # of Push-up completed

    Upper body endurance will be assessed via a standard push-up test. The total number of correctly executed push-ups will be recorded

    Measured: Performed at baseline and 14-days after wearing the smartwatch

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Feb 2025
  2. Study start1 Jan 2025
  3. Primary completion20 Aug 2025
  4. Study completion25 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06805422
Sponsor's protocol ID
KansasSU
Other IDs
IRB-12223
Status last verified
Aug 2025
First submitted
27 Jan 2025
Last updated
26 Aug 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Exercise Capacity and Flexibility, run by Kansas State University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 15 inclusion and 22 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 26 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Maximum Oxygen Consumption (VO2max) (time frame: Performed 14-day after wearing the smartwatch). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Aug 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in